Scholars Central

Conference abstractPublished 17 Mar 2022

Results of treatment with myo-Inositol and D-chiroinositol combination in ratio 5:1 in women with clinical and biochemical hyperandrogenemia associated with polycystic ovary syndrome

Authors: Victoria Prilutskaya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hyperandrogenemia is a part of the Polycystic Ovary Syndrome (PCOS), which occurs in 5-8% of women of reproductive age. An interventional single-center prospective study was conducted at Sechenov University from October 2020 to June 2021. We compared the effectiveness of the combination of myoinositol (MI) and D-chiro-inositol (DHI) in a ratio of 5:1 and standard antiandrogenic therapy (COC containing ethinylestradiol 0,02 mg with drospirenone 3 mg) for the treatment of clinical and biochemical hyperandrogenism, as well as assessed the degree of anxiety on the Spielberger-Khanin anxiety scale before and after therapy. Patients of the main group (N=53, aged 26.6±3.62) received an oral combination of 1000 mg MI and 200 mg DHI in a ratio of 5:1, 2 times a day after meals. Patients of the control group (N=55, aged 27.1±2.54) received COC for 6 months. The assessment of hirsutism on the Ferriman-Gallway (FG) scale, the severity of acne on the G. Plewig, M. Kligman scale were carried out initially and 2 months after the discontinuation of therapy. The results of the study showed that the combination of MI with DHI in a ratio of 5:1 can be considered as an effective alternative therapy for the treatment of hyperandrogenemia in patients with PCOS due to a decrease in the levels androgens in the serum blood and decrease in the severity of acne and hirsutism. An improvement in the psychoemotional state of the patients due to a decrease in anxiety was more common in group 1 than in group 2.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Gynecology & Obstetrics Case report.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGynecology & Obstetrics Case report
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Victoria Prilutskaya”